Masashi Takano
- Reproductive Medicine top 0.1%
- Molecular Biology top 5%
- Obstetrics and Gynecology top 0.2%
- Oncology top 2%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Hitoshi TsudaSohei YamamotoOsamu MatsubaraSeiichi TamaiToru SugiyamaMorikazu MiyamotoTomoko GotōKenichi Furuya
- Topics
- Ovarian cancer diagnosis and treatment (112 papers)Endometrial and Cervical Cancer Treatments (49 papers)Vitamin D Research Studies (26 papers)
- Journals
- Journal of the American Chemical SocietyJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Masashi Takano
242 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 113
- Reproductive Medicine 2.6k
- Molecular Biology 1.8k
- Obstetrics and Gynecology 1.5k
- Oncology 1.2k
- Pathology and Forensic Medicine 936
Countries citing papers authored by Masashi Takano
This map shows the geographic impact of Masashi Takano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masashi Takano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masashi Takano more than expected).
Fields of papers citing papers by Masashi Takano
This network shows the impact of papers produced by Masashi Takano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masashi Takano. The network helps show where Masashi Takano may publish in the future.
Co-authorship network of co-authors of Masashi Takano
This figure shows the co-authorship network connecting the top 25 collaborators of Masashi Takano. A scholar is included among the top collaborators of Masashi Takano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masashi Takano. Masashi Takano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 5 | |
| 7 | 5 | |
| 8 | 10 | |
| 9 | 8 | |
| 10 | 8 | |
| 11 | 7 | |
| 12 | UGT1A1 genotype-specific phase I and pharmacokinetic study for combination chemotherapy with irinotecan and cisplatin: a Saitama Tumor Board study. | 5 |
| 13 | 20 | |
| 14 | 9 | |
| 15 | 9 | |
| 16 | 13 | |
| 17 | 37 | |
| 18 | [Recent progress of study on vitamin D analogs]. | 2 |
| 19 | 0 | |
| 20 | 0 |
About Masashi Takano
Masashi Takano is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Pathology and Forensic Medicine, having authored 255 papers that have together received 5.5k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (112 papers), Endometrial and Cervical Cancer Treatments (49 papers) and Vitamin D Research Studies (26 papers). The work is most often cited by research in Reproductive Medicine (2.6k citations), Obstetrics and Gynecology (1.5k citations) and Pathology and Forensic Medicine (936 citations). Masashi Takano has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Hitoshi Tsuda, Sohei Yamamoto, Osamu Matsubara, Seiichi Tamai, Toru Sugiyama, Morikazu Miyamoto, Tomoko Gotō, Kenichi Furuya, Nobuo Yaegashi and Yoshihiro Kikuchi. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.